Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety of Iodine-131 Anti-B1 Antibody, to see what
effects it has on patients with CLL and to determine the highest dose of Iodine-131 Anti-B1
Antibody that can be given without causing severe side effects.